Fortress Biotech, Inc. (FBIO) Stock: A Biotech Stock That’s Seeing Declines


Fortress Biotech, Inc. (FBIO) is working its way for to the bottom in the market today. The stock, one that is focused in the biotechnology sector, is presently trading at $1.26 after a move down of -8.03% so far today. In terms of biotech stocks, there are several aspects that have the potential to lead to declines in the market. One of the most common is news. Here are the most recent stories associated with FBIO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-12-19 10:13AM Have Insiders Been Selling Fortress Biotech, Inc. (NASDAQ:FBIO) Shares?
Jul-01-19 08:30AM Checkpoint Therapeutics Added to Russell 2000® Index
Jun-03-19 07:00AM Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
May-23-19 08:30AM Mustang Bio and St. Jude Childrens Research Hospital to Participate in Panel Discussion at Boston CEO 2019
May-17-19 09:35AM Will Fortress Biotech to Surge Higher?

However, any time investors are making an investing decision, investors should look into far more than news, this is especially the case in the speculative biotech industry. Here’s what’s going on with Fortress Biotech, Inc..

What We’ve Seen From FBIO

While a single session decline, like what we’re seeing from Fortress Biotech, Inc. may lead to fear in some investors, a single session move by itself should not be the reason for a decision to, or not to, invest in a company. It’s always important to look into trends experienced by the stock further out than a single trading day. When it comes to FBIO, here are the returns on investment that we have seen:

  • Weekly – Throughout the past week, FBIO has seen a price change in the amount of -20.75%.
  • Monthly – The performance from Fortress Biotech, Inc. throughout the last 30 days has been -31.89%.
  • Past Quarter – Over the last three months, the stock has produced a ROI of -13.70%
  • Bi-Annually – Over the previous six months, we have seen a performance that works out to 2.44% from the stock.
  • Year To Date – Since the close of last year FBIO has produced a ROI of 46.51%.
  • Annually – Finally, over the last full year, we have seen performance amounting to -55.00% out of FBIO. In this period of time, the stock has sold at a high price of -55.16% and a low of 157.14%.

Ratios Of Note

Looking at a few key ratios having to do with a stock can provide traders a view of how dangerous and/or rewarding a an investment option may be. Here are a few of the key ratios to think about when digging into FBIO.

Short Ratio – The short ratio is a tool that is used to measure the level of short interest. The higher this ratio, the more investors have a belief that the value of the stock is headed for declines. Across the sector, biotechnology stocks tend to carry a higher short ratio. On the other hand, we also see quite a few short squeezes in the space. Nonetheless, when it comes to Fortress Biotech, Inc., it’s short ratio clocks in at 3.46.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Basically, they measure If a company is able to pay its debts as they mature using quick assets or current assets. In the biotechnology sector, several companies are heavily reliant on the continuation of support from investors, these ratios can seem upsetting. Nonetheless, some better companies in the biotechnology sector do have positive current and quick ratios. As it relates to FBIO, the quick and current ratios total up to 2.80 and 2.80 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets owned by the company to the share price. when it comes to Fortress Biotech, Inc., the book to share value ratio comes in at 0.43.

Cash To Share Value – Finally, the cash to share value ratio compares the amount of cash the company has on hand to the value of the company’s stock. Several clinical stage biotech companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotechnology space, this is a very important ratio to think about. In terms of FBIO, the cash to share value ratio comes to 1.71.

Analyst Opinions With Regard To Fortress Biotech, Inc.

Although it’s never a smart idea to avoid doing your due diligence and blindly following the thoughts of analysts, it is a smart idea to use their thoughts to validate your own thoughts before making an investment decision in the biotech sector. Here are the most recent moves that we’ve seen from analysts when it comes to FBIO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-28-18 Initiated B. Riley FBR, Inc. Buy $10
Jul-11-17 Initiated Rodman & Renshaw Buy $11
Mar-22-17 Initiated JMP Securities Mkt Outperform
Oct-03-16 Initiated ROTH Capital Buy $9

Is Big Money Interested in Fortress Biotech, Inc.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in FBIO, here’s what we’re seeing:

  • Institutions – Currently, institutions hold 13.80% of Fortress Biotech, Inc.. However, it’s important to note that institutional ownership has seen a move in the amount of 1.19% throughout the last 3 months.
  • Insiders – with regard to insiders, those close to the situation currently hold 0.70% of the company. Their ownership of the company has changed by 0.00% over the past 3 months.

A Look At Share Counts

Traders tend to like to know the amounts of shares both available and outstanding. In regard to Fortress Biotech, Inc., there are currently 70.94M and there is a float of 44.92M. These numbers mean that of the total of 70.94M shares of FBIO in existence today, 44.92M are able to be traded by the public.

It’s also important to dig into the short float. Think about it, if a large percentage of the float is sold short, the overall feeling in the market is that the equity is going to fall hard. As far as it relates to FBIO, the short percentage of the float is currently 6.37%. Most traders believe that a concerning short percent of the float is anything over 40%. Nonetheless, I have calculated that any short percent of the float over 26% is likely a play that comes with hefty risk.

What We’ve Seen In Financial Results

What have ween seen from FBIO in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – Currently, analysts expect that the company will generate EPS coming to a total of -1.75, with -0.46 being announced in the earnings report for the current quarter. Although this data is not earnings driven, since we are talking on the topic of Wall Street analysts, the stock is currently rated a 2.00 considering a scale that ranges from 1 to 5 where 1 is the poorest possible Wall St. analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the last half decade, Fortress Biotech, Inc. has announced a movement in revenue that adds up to 0. Earnings through the period have seen a change of -6.60%.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is generally referred to as in today’s society, Fortress Biotech, Inc. has generated a earnings change by 104.90%. Fortress Biotech, Inc. has also experienced a change in regard to sales volume that amounts to 10.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an AI. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings actually play a crucial role in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but I learn much faster when I have a teacher. If you would to help me learn something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here